Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Darb-ESA 25mcg Injection
Manufacturer/Marketed By : SEPTALYST LIFESCIENCES PVT LTD
$16.96 $13.58
Darb-ESA 25mcg injection is an antineoplastic medication that belongs to a class of drugs known as hematopoietic growth factors. It contains the active compound Darbepoetin Alfa . It is used...
Collapsible text is perfect for longer content like paragraphs and descriptions. It's a great way to give people more information while keeping your layout clean. Link your text to anything, including an external website or a different page. You can set your text box to expand and collapse when people click, so they can read more or less info.
DARBEPOETIN ALFA
Active Pharmaceutical Ingredient
Darb-ESA 25mcg Injection
$16.96
$13.58
Darb-ESA 25mcg injection is an antineoplastic medication that belongs to a class of drugs known as hematopoietic growth factors. It contains the active compound Darbepoetin Alfa . It is used to treat anemia in people with chronic kidney disease. and anemia caused by chemotherapy in people with certain types of cancer. It is not recommended to take Darbepoetin alfa if you are allergic to active compounds or any other ingredients of this medicine. It is recommended to monitor complete blood count before starting the therapy. It is not recommended for use in patients who have uncontrolled blood pressure. It is not recommended for use in patients who receive cancer treatment with hormonal drugs and radiotherapy. It is not advised to be used in place of red blood cell transfusions in individuals in need of immediate anemia correction. Inform your physician if you have high blood pressure, anemia, a history of seizures, epilepsy, liver disease, or allergy to latex or hepatitis C. Inform your physician if you are pregnant or breastfeeding. Before initiating the treatment, inform your physician if you have fever, blood clots, any infections, kidney, heart or liver problems. Your doctor will monitor your haemoglobin levels to ensure they stay within a specified range. High haemoglobin concentrations can increase your chance of developing heart or blood vessel problems. It is necessary to inform your physician about all the medicines, over the counter drugs, vitamin and herbal supplements you are taking before the start of therapy.
Active Pharmaceutical Ingredient
Uses
• To treat anemia in chronic kidney failure
• To treat anemia caused by chemotherapy
Benefits
Darb-ESA 25mcg injection is an erythropoiesis-stimulating protein produced by recombinant DNA technology. The erythropoietin receptor on the surface of erythroid progenitor cells in the bone marrow is bound by Darb-ESA 25mcg injection and activated. This activation sets off a signaling cascade that increases the erythroid progenitor cells' ability to survive, proliferate, and differentiate, ultimately increasing the generation of red blood cells.
Side Effects
Side effects are unwanted symptoms caused by medicines. Even though all drugs cause side effects, not everyone gets them.
Most Common Side Effects
• Heart problems
• Severe skin reactions
• Anemia
• Seizure attack
• Lung problems
Common Side Effects
• Swelling in the face and body
• Low blood pressure
• Abdominal pain
• Shortness of breath
• cough
How To Use
The injection is to be administered subcutaneously, or beneath the skin. Your doctor will provide you instruction on how to use this pre-filled pen for self-injection. If you are not well-trained, do not attempt to inject the pre-filled pens. Never put the medication intravenously. Visit the hospital or clinic in the area if you require assistance administering the medication.
Safety Advice
• Breast Feeding: Darb-ESA 25mcg injection is not recommended during breastfeeding, as it is unknown if Abemaciclib is excreted in human milk. Because of the potential risk to the infant, breastfeeding is not recommended.
• Alcohol: It is typically advised that patients taking Darb-ESA 25mcg injection avoid or consume alcohol in moderation since it can worsen any liver-related adverse effects and raise the risk of liver damage.
• Liver: Dose adjustments are necessary for patients with liver disorders. Inform your physician if you have any liver diseases or problems before initiating the therapy.
• Lungs: It is unknown whether Darb-ESA 25mcg injection can be used in patients with lung disorders. Consult your doctor if you have any lung diseases before starting the treatment.
• Driving: Darb-ESA 25mcg injection will not make you feel tired, dizzy, or sleepy. It is safe to drive or operate heavy machinery after taking this medicine.
• Pregnancy: There are no adequate and well-controlled studies on the use of Darb-ESA 25mcg injection in pregnant women. Inform your physician if you are pregnant, suspecting, or planning for pregnancy during the treatment.
Disclaimer
Sidmex Inovia strives to provide accurate and reliable information; however, all content on this website, including product descriptions and compositions, is for informational purposes only and should not be considered a substitute for professional medical advice, diagnosis, or treatment.
Users are advised to consult a qualified healthcare professional before making any medical decisions. The information provided should not be used for self-diagnosis or self-medication.
All products listed are intended strictly for B2B and bulk inquiry purposes only. Sidmex Inovia does not promote direct consumer use and aims to support, not replace, the healthcare professional–patient relationship.
Product names, trademarks, and brands belong to their respective owners, and their use does not imply any affiliation or endorsement. Sidmex Inovia shall not be held responsible for any consequences arising from the use of the information provided on this website.